New York's Office of Cannabis Management has issued a precautionary recall for 54 adult-use cannabis product lots and one heavy metal product lot, citing unreliable testing results from Keystone State Testing New York, raising concerns about consumer safety and regulatory oversight.

New York Cannabis Market Shaken by Major Product Recall Over Unreliable Lab Testing

The New York State Office of Cannabis Management (OCM) has initiated a significant precautionary recall of numerous adult-use cannabis products after investigations revealed unreliable testing results from Keystone State Testing New York. This recall affects 54 product lots found to have falsely reported results for Aspergillus, a disease-causing mold, which did not meet state safety standards. Additionally, one product lot incorrectly reported heavy metal (Cadmium) levels, failing to meet consumption safety standards. While OCM has not received any reports of adverse health effects, the action underscores a proactive approach to consumer safety. The unreliable certificates of analysis issued by Keystone State Testing New York, following inspections and a records audit between December 2025 and January 2026, represent a violation of New York's Cannabis Law and regulations. Consumers who purchased affected products are advised to return them to the retail dispensary. OCM officials, including Executive Deputy Director Stephen Geskey and Chief Medical Officer Dr. June Chin, emphasized the critical role of accurate testing in ensuring product safety and maintaining public confidence in the regulated market.

Sheeba Insight

"Well, well, well, looks like New York's cannabis market just got a wake-up call, and it's ringing loud and clear for investors. The OCM's recent recall over unreliable testing from Keystone State Testing New York isn't just a minor blip; it's a stark reminder of the fragile trust consumers place in regulated cannabis. When labs fail to deliver accurate results, especially on critical contaminants like Aspergillus mold and heavy metals, it erodes confidence faster than a joint on a windy day. For our tracked companies like , , , and , while this specific recall isn't directly on their doorstep, the broader implications are impossible to ignore. This incident spotlights the paramount importance of robust quality control and rigorous, verifiable testing across the entire supply chain. Investors should be watching closely how other states and indeed, these multi-state operators, respond to this kind of regulatory scrutiny. Will it trigger more stringent auditing? Will it pressure companies to diversify their testing partners or bring more in-house? The 'trust factor' is a powerful currency in this burgeoning industry, and any cracks in that foundation, especially around consumer safety, can have ripple effects on stock performance and market perception. It reinforces the 'moat' for companies with impeccable internal QA, and it puts a target on the back of any operator cutting corners on testing. This isn't just about New York; it's a playbook for how regulatory bodies will react when safety is compromised. Smart money will be looking for transparency and a clear commitment to consumer welfare, because a healthy consumer base is, after all, the bedrock of a thriving cannabis investment. Keep an eye on the labs your favorite cannabis companies are using, because as New York just proved, trust but verify, and then verify again."

Safe Harbor Financial reports a robust 29% year-over-year growth in emerging U.S. cannabis markets, driven by strategic early entry into key states and over 100 new customer accounts, signaling a maturing industry and increasing demand for compliant financial services.

Safe Harbor Financial Rides Wave of Growth in Emerging US Cannabis Markets, Bolstering Industry Infrastructure

DENVER – March 5, 2026 – SHF Holdings, Inc., operating as Safe Harbor Financial (NASDAQ: SHFS), a leading fintech platform for the regulated cannabis and hemp industries, announced impressive growth figures for emerging U.S. cannabis markets. Over the 12 months ending February 4, 2026, the company saw a 29% increase in emerging market average deposit balances, contributing to a 4.5% rise in total average deposit balances. These emerging markets now constitute 31% of Safe Harbor’s total average deposit balances, a testament to their strategic focus on high-potential state markets.

Terry Mendez, CEO of Safe Harbor, highlighted the company’s success in building a strong foundation through early investment in various market categories: newly launching state programs (Delaware, Minnesota, Kentucky, Alabama, Mississippi), established states expanding adult-use licensing (New York, New Jersey, Maryland, Connecticut, Missouri, Ohio), and mature markets where existing operators are expanding their operations (Pennsylvania, Illinois, Virginia, Florida). This growth has translated into over 100 new customer depository accounts and increased deposits from existing clients, solidifying Safe Harbor’s position as a trusted financial partner across the cannabis industry’s evolving landscape. The company emphasizes its role in supporting cannabis operators from initial licensing through operational maturity, anticipating continued expansion as state programs evolve.

Sheeba Insight

"This Safe Harbor Financial report, boasting nearly 30% growth in emerging markets, isn't just about one financial platform; it's a neon sign flashing 'opportunity' for the entire cannabis investment landscape. For the savvy investor eyeing multi-state operators like , , , and , this growth in financial infrastructure is a critical, albeit often overlooked, component of sector maturation. It signals a de-risking of operations as more compliant banking solutions become available, which can translate into greater operational efficiency and potentially improved valuations for MSOs navigating complex regulatory environments.

The strategic focus on states with new programs and expanding adult-use licensing, such as New York, New Jersey, and Ohio, is particularly telling. These are battlegrounds for market share, and companies that can secure stable, compliant banking will have a significant competitive advantage. For and , both with substantial footprints and ambitions for further expansion, access to sophisticated financial services like those provided by Safe Harbor is paramount. It allows them to focus on core business growth rather than grappling with banking hurdles.

Furthermore, the increase in deposit balances and new customer accounts underscores a broader trend: the normalization of cannabis as a legitimate industry. As more capital flows through regulated channels, it fosters greater transparency and reduces the 'grey market' stigma that has historically plagued the sector. This institutional embrace, even from financial service providers, paves the way for greater mainstream investment and a more robust, stable market. While the headlines often focus on legislative changes, the quiet, consistent build-out of supporting infrastructure like compliant banking is arguably just as, if not more, impactful for long-term investor confidence. Keep an eye on the states Safe Harbor is targeting; they’re often leading indicators of where the next big growth stories in cannabis will emerge."

Last Updated: Mar 4, 2026

TL;DR Cannabis biotech offers precision medicine, synthetic cannabinoids, and genetic advancements for long-term growth.

Last Updated: Mar 4, 2026

TL;DR Cannabis drinks emerging as a potential safer alternative to alcohol, reducing negative consequences.

Last Updated: Mar 4, 2026

TL;DR Federal hemp law changes in November 2026 could make millions of CBD products illegal—a major threat to the multi-billion-dollar CBD market.